is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Over the course of the last few months, we have been in constant discussion with partners and key industry stakeholders to stay abreast of the challenges and complexities that each sector of the pharma industry is facing due to COVID-19.
This has included working closely with all partners and key industry stakeholders involved in CPhI Japan to determine if the show scheduled for September 2020 in Osaka would be both practical and beneficial to the market.
From a health and safety standpoint, we felt confident we could deliver a safe and secure event incorporating the highest hygiene standards.
However, CPhI Japan is an international event that attracts key industry players from around the globe. With international travel only returning gradually, Japan’s borders currently closed and each country at a different stage of recovery following the COVID-19 outbreak, it has become apparent that it would be difficult to guarantee the level of participation and high-quality experience expected of CPhI Japan.
We have agreed with our partners and key industry stakeholders to postpone CPhI Japan until 14-16 April 2021 and focus on other ways in which we can support the pharma industry in the remainder of 2020, with a commitment that CPhI Japan will return stronger than ever next year.
By acting now, we hope to provide you with enough time to adjust your travel plans, avoid unnecessary expense and adapt to new opportunities the CPhI group has developed to fill the gap left by our in-person events in 2020.
Event Alternatives: Digital Networking & Learning
Whilst we will not be able to hold our in-person event in Osaka this year, we are looking into alternative digital opportunities that the CPhI Japan community can take advantage of.
We recognise that networking and knowledge sharing on a global scale is of utmost importance for Japanese manufacturers to deliver drugs to the market in a consistent way, so we endeavour to share the online opportunities that will allow this with you as soon as possible.
We sincerely apologise for any inconvenience caused and appreciate your understanding and cooperation during these unprecedented times.